Drug Trial Radar · NCT02158572
Efficacy, Safety and Tolerability Study of Agile AG200-15 Transdermal Contraceptive Delivery System
Last checked: Nov 19, 2026Latest source record: May 6, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,032
Actual
Start
Aug 2014
Primary completion
Nov 2016
Study completion Nov 2016
Sponsor
- Lead sponsor
- Agile TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Jun 9, 2014
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Female only
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Study of the efficacy of a contraceptive patch in 2100 healthy women for up to one year.
Conditions
- Healthy
Interventions
AG200-15Drug
Transdermal contraceptive delivery system
Primary outcomes
What the sponsor says the trial is designed to measure.
- Contraception Efficacy of AG200-15 in Subjects ≤ 35 Years of Age Regardless of BMI, Intent-to-treat (ITT) Dataset.Time frame: 1 year
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.